Our cutting-edge products lead the way in neuroendovascular therapies.


We set the bar high for ourselves and it wouldn’t be possible without a collaborative work environment that values professional growth and innovation. Come work alongside us in a rewarding and relaxed environment.

Work with us

Latest News

Sep 29, 2022

MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives

MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corporation, celebrates its 25-year anniversary on September 29, 2022. Founded in 1997 by a handful of Associates in a small facility in Southern California, MicroVention is now a worldwide community with over 3,000 Associates and distributors worldwide, operating in over 70 countries with offices across the United States, Europe, Asia, and Costa Rica.

Read more
Sep 21, 2022

MicroVention Earns 2022 Great Place to Work Certification™

The prestigious award is based entirely on what current employees say about their experience working at MicroVention. This year, 80% of employees said it’s a great place to work – 21 points higher than the average U.S. company.

Read more
Apr 20, 2022

MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide Catheter

MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke.

Read more
Feb 22, 2022

MicroVention Announces First U.S. Patient Treated with FRED™ X™ Flow Diverter Featuring X Technology

MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, announced the first U.S. clinical case of its next generation Flow Diverter, the FRED X device, at Thomas Jefferson University Hospital located in Philadelphia.

Read more

Upcoming Events